Simultaneous multi-analyte urinary protein assay for bladder cancer detection

BMC Biotechnology

Table 1 Demographic and clinicopathologic characteristics of 73 subjects comprising study cohort

	Bladder cancer	Benign controls
	n = 31	n = 42
Median Age (range, y)	71 (54–93)	62 (24–81)
Male : Female ratio	26:5	35:7
Suspicious/positive cytology	32%	0%
Clinical stage
Tis	3	N/A
Ta	12	N/A
T1	2	N/A
≥T2	14	N/A
Tumor grade
Low	4	N/A
High	27	N/A

ISSN: 1472-6750